Home > Financial Ratios > AJANTA PHARMA

AJANTA PHARMA
EV/Core EBITDA

    Back to All Ratios
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 22.3216.8914.5814.9415.16

What is the latest EV/Core EBITDA ratio of AJANTA PHARMA ?

The latest EV/Core EBITDA ratio of AJANTA PHARMA is 22.32 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202422.32
Mar202316.89
Mar202214.58
Mar202114.94
Mar202015.16

How is EV/Core EBITDA of AJANTA PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 22.32
32.15
Mar2023 16.89
15.84
Mar2022 14.58
-2.41
Mar2021 14.94
-1.45
Mar2020 15.16 -

Other Financial Ratios of AJANTA PHARMA


Compare EV/Core EBITDA ratio of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹31,068.9 Cr -4.6% -7.1% 24.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,430.0 Cr -3% -8.7% 4.1% Stock Analytics
DIVIS LABORATORIES ₹145,410.0 Cr -4.7% -4.5% 58.5% Stock Analytics
CIPLA ₹113,950.0 Cr -4.3% -3.2% -3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹99,682.3 Cr -3% -12.3% 13.8% Stock Analytics
DR REDDYS LABORATORIES ₹93,261.6 Cr -3% -6.5% -12.7% Stock Analytics


AJANTA PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-4.6%

-7.1%

24.4%

SENSEX

-3.4%

-4.4%

0.6%


You may also like the below Video Courses